← Atlas Theme · spans 1 topics
Geopolitical rivalry forces sovereign regulators to overhaul early-stage clinical trial trial structures.
To prevent clinical research and pharmaceutical pipelines from migrating to global competitors like China, home states are introducing expedited pilot pathways and pilot programs.
1
Topics it spans
2
Findings citing it
—
Evidence window
The convergence
The same conclusion keeps arriving from across the workspace's research — 1 topics independently instantiate this theme. Filter the evidence by where it came from:
Science & Health
HHS and FDA's "Operation Trialblazer": Accelerating Clinical Trials — Now with ARPA-H's SURPASS, STACK, COMMONS, and CINCH The HHS launched 'Operation Trailblazer' specifically to reform and accelerate U.S. clinical trials to prevent pharmaceutical pipelines from migrating to Chinese competitors.
Science & Health
FDA Launches Expedited IND Pilot Under Operation TrialBlazer — Applications Open Through October 30, 2026 Faced with swift translational pipelines in competing foreign nations, the FDA launched the Expedited IND Pilot Program to modernize and accelerate domestic early-stage research.